Medtronic inks exclusive deal to sell Kuros bone graft device
In the five-year agreement, Medtronic will be the exclusive sales agent for Kuros' product in certain U.S. spine geographies.
MassDevice2d
Medtronic spinal division inks agreement with Kuros Biosciences
Kuros Biosciences USA's strategic, exclusive sales agency agreement with Medtronic could boost adoption of its MagnetOs bone ...
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division
Kuros Biosciences AG / Key word (s): Agreement Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division 07-Jan-2025 / 07:00 CET/CEST Release of an ad ...
Becker's Spine Review3d
Medtronic inks partnership for spinal biologics
Medtronic and Kuros Biosciences signed a strategic agreement to support sales of the MagnetOs bone graft technology.
Becker's Spine Review2d
4 medtech notes: Medtronic, Stryker and more
From new partnerships to acquisitions, here are four key developments from spine and orthopedic medtech companies since Jan. 1.
EurekAlert!10d
Custom-fit bone grafts: the future of craniomaxillofacial surgery
A recent review is transforming the landscape of craniomaxillofacial bone regeneration with the introduction of personalized ...
Yahoo Finance1mon
Kuros Biosciences Expands into Extremities Markets
With three of the MagnetOs formulations already indicated ... strengthening our position as a premier advanced bone healing company across multiple musculoskeletal markets." ...
Kuros Biosciences AG: Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division
Medtronic will act as the exclusive sales agent of MagnetOsTM for Kuros Biosciences USA, Inc. in mutually agreed upon sales territories for use in spine surgeriesKuros will work collaboratively to sel ...